Home › Trial NCT05700149
Integrated Molecular and Clinical Profiling to Improve Disease Characterization and Outcome Prediction in Nodal Marginal Zone Lymphoma
- Trial IDNCT05700149
- StatusRecruiting
- PhaseN/A
- Study typeObservational
- SponsorInternational Extranodal Lymphoma Study Group (IELSG)
- Enrollment300
- Start date2024-04-11
- ConditionsNodal Marginal Zone Lymphoma
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.